The Influence of Cholinergic System on Rheumatoid Arthritis
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2019, Vol 3, Issue 1
Abstract
Rheumatoid arthritis is one of the most prevalent immune-mediated arthritis and is categorized as a chronic, inflammatory and autoimmune disease, which mainly affects the cartilage, synovial joint, and bone, the causes of which remain unknown. There are different factors playing a role in RA pathophysiology on the molecular level, like Citrullination, Regulatory T cells, Monocytes, Macrophages, Platelet microparticles, and RASFs, which mainly induce inflammation by producing pro-inflammatory cytokines such as IL-8, IL-6, IL-1, and TNF. We have two types of cholinergic systems (CS) in our body, Neuronal CS, in which Acetylcholine (ACh) act as a neurotransmitter and NonNeuronal CS in which ACh act as a local signalling molecule for cellular proliferation and regulation of cellular function including the cells involved in RA inflammation. In light of the recent studies, the links between the CS and cells involved in RA molecular pathophysiology suggest new approaches for controlling RA, which will be discussed further. First, is the stimulation of the vagus nerve, which plays an essential role in the cholinergic anti-inflammatory pathway through its main neurotransmitter ACh resulting in downregulation of TNFα and inhibition of inflammation. The second strategy is stimulation of CAP by selective activation of α7nAChR, which is represented by different types of immune cells, such as T and B-lymphocytes, monocytes, dendritic cells, especially macrophages, and FLS through acetylcholine or its selective agonist resulting in decreased TNF production and reduced inflammation. As we discussed previously ACh is one of the necessary components for cellular proliferation especially in RASFs. Choline transporter-like proteins 1 and 2 are accountable for bringing extracellular choline inside the RASFs, which further will convert to ACh within the cell. Therefore, as the final strategy, we can induce apoptotic cell death in RASFs through preventing choline uptake by CTL1 and CTL2. Blocking of choline uptake through Choline transporter-like proteins 1 and 2, presents a novel target for RA treatment, but further in vivo studies are necessary to examine the role of these transporters as drug targets in RA.
Authors and Affiliations
Mehranfard D* and Hamurtekin E
Keywords
Related Articles
- EP ID EP745929
- DOI 10.23880/oajpr-16000170
- Views 1
- Downloads 0
Diclofenac Sodium Loaded Nanosized Ethosomes: An Investigation on Z-Average, Polydispersity and Stability
Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID). Oral therapy with NSAID is always associated with several side effects such as gastric bleeding, and ulceration. The purpose of this work was to explor...
Computer-Based Pharmacognosy: A Review
In search of modern ways to increase secondary metabolites production in plants, implement genetic engineering, and produce green pollution-free medicinal plants, modern computer-based techniques must be regarded. The in...
Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol)
Objective: FAC (5 fluorouracil, Adriamycin and cyclophosphamide) and AC (Adriamycin and cyclophosphamide) protocols have significant anti-tumor activity in patients with breast cancer. Our objective was to evaluate the C...
Pharmacy Education in Egypt
Egypt is a developing nation that occupies an important geographic and historic position in the heart of the Middle East. It is located in the cross roads between Africa, Asia and Europe. Its population is approximately...
Consequence of Adsorption Chromatography
Chromatography classify based on separation mechanism, Adsorption chromatography is one type that is developed first, where the stationary phase has solid and mobile phase has a liquid or gaseous. When drugs are manufact...